Marshall Wace’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
700
-100
-13% -$1.55K ﹤0.01% 3072
2026
Q1
$10.8K Buy
+800
New +$11.2K ﹤0.01% 3091
2021
Q4
Sell
-14,900
Closed -$202K 4312
2021
Q3
$202K Buy
+14,900
New +$211K ﹤0.01% 2801

Other funds holding VTRS

Marshall Wace's VTRS Position: Q2 2026 in Review

Marshall Wace reduced its Viatris (VTRS) stake by 91% in Q2 2026, selling an estimated $132M and leaving 839,820 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #915.

Marshall Wace first reported a position in VTRS in Q1 2014 and has held it in 30 quarters since. The position peaked at $126M in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Marshall Wace held 839,820 shares of Viatris worth $13.3M as of Q2 2026.
  • Marshall Wace sold 8,509,997 Viatris shares in Q2 2026, an estimated $132M.
  • Viatris made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #915 holding.
  • Marshall Wace first reported a position in Viatris in Q1 2014 and has held it in 30 quarters since.
  • Marshall Wace's Viatris position peaked at $126M in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.